BioCardia Q4 EPS $(0.06) Beats $(0.17) Estimate

BioCardia (NASDAQ: BCDA) reported a Q4 loss of $(0.06) per share, surpassing the analyst estimate of $(0.17) by 64.71%. This marks a 76% improvement compared to losses of $(0.25) per share in the same quarter last year.